Randomized Trials: Some Further Issues

Comprehensive vocabulary flashcards covering key statistical concepts, error types, clinical trial phases, validity definitions, and landmark randomized controlled trials from Chapter 11.

Type I Error ($\alpha$)

The error that occurs when researchers conclude that treatments differ when, in reality, they do not differ. Its probability is designated as $\alpha$.

Type II Error ($\beta$)

The error that occurs when researchers conclude that treatments do not differ when, in reality, they do differ. Its probability is designated as $\beta$.

Statistical Power ($1 - \beta$)

The probability of correctly concluding that treatments differ, representing the likelihood of detecting a true difference between treatments if one actually exists ($1 - \beta$).

Sample Size Estimation Requirements

The five parameters required prior to starting a trial: the difference in response rates to be detected, an estimate of response rate in one group, level of statistical significance ($\alpha$), desired power ($1 - \beta$), and whether the test is one-sided or two-sided.

Efficacy

A measure of how well a treatment reduces disease risk under ideal conditions, calculated as: $\text{Efficacy} = \frac{(\text{Rate in placebo group}) - (\text{Rate in vaccine group})}{\text{Rate in placebo group}}$.

Number Needed to Treat (NNT)

The number of patients who must receive a treatment to prevent one adverse outcome (such as death), calculated as: $\text{NNT} = \frac{1}{(\text{Rate in untreated group}) - (\text{Rate in treated group})}$. Estimates are typically rounded up to the next whole number.

Number Needed to Harm (NNH)

A metric indicating the number of individuals exposed to an intervention that would result in one additional patient experiencing a specific side effect or adverse outcome.

External Validity (Generalizability)

The extent to which the findings obtained from a randomized trial's study population can be generalized to the defined population and, ultimately, to the total population.

Internal Validity

The degree to which a randomized trial is conducted properly without methodological bias, ensuring that conclusions regarding treatment differences are valid within the study population.

Comparative Effectiveness Research

Studies comparing two or more existing interventions directly to determine which intervention works best in a given population or for an individual patient.

Noninferiority Studies (Equivalence Studies)

Clinical investigations designed to demonstrate whether a newer, less expensive, or less invasive treatment is as effective as an existing standard or more expensive treatment.

Superiority Studies

Comparative trials conducted to demonstrate that a newly developed therapeutic agent or intervention is more effective than currently available interventions.

Phase I Clinical Trial

Small clinical pharmacologic investigations ($n = 20\text{--}80$) designed primarily to evaluate drug safety, pharmacologic actions, and toxic effects in humans.

Phase II Clinical Trial

Clinical investigations involving $n = 100\text{--}300$ participants designed to evaluate treatment efficacy and further assess relative drug safety.

Phase III Clinical Trial

Large-scale randomized controlled trials ($n = 1{,}000\text{--}3{,}000$) evaluating treatment efficacy and relative safety; successful completion enables regulatory approval and marketing licensure.

Phase IV Clinical Trial

Post-marketing surveillance studies conducted after drug approval to monitor safety, efficacy, and adverse effects during widespread real-world clinical use.

Publication Bias

The selective reporting or publishing of clinical studies with positive results while withholding negative, neutral, or harmful results, which distorts medical evidence.

ClinicalTrials.gov

The official federal online registry and repository established to record clinical trials prior to participant enrollment to ensure transparency and reduce publication bias.

Systematic Review

A rigorous, protocol-driven methodology that comprehensively identifies all published research on a specific clinical question, evaluates study quality via risk of bias assessment, and qualitatively synthesizes findings.

Meta-analysis

The quantitative statistical synthesis and mathematical combination of effect estimates across multiple individual studies identified in a systematic review.

PROSPERO

The International Prospective Register of Systematic Reviews, used to prospectively register protocols for systematic reviews to maintain transparency and prevent selective reporting.

Salk Polio Vaccine Trial (1954)

A historic, large-scale randomized field trial conducted in 1954 that demonstrated the effectiveness of the inactivated polio vaccine in school-aged children.

Physicians' Health Study (1982–1988)

A major randomized controlled trial evaluating the efficacy of aspirin in the primary prevention of cardiovascular disease and myocardial infarction.

Women's Health Initiative (WHI – HRT Trial)

A large-scale randomized trial ($1991\text{--}2005$) evaluating the effects of postmenopausal hormone replacement therapy on cardiovascular disease and cancer outcomes.

Diabetes Prevention Program (DPP, 2002)

A clinical trial demonstrating that intensive lifestyle modifications or metformin significantly reduce the incidence of type 2 diabetes in high-risk individuals.

HPTN 052 Trial (2011)

A landmark randomized trial demonstrating that early initiation of antiretroviral therapy (ART) prevents sexual transmission of HIV in serodiscordant couples.

ALLHAT Trial (2002)

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, designed to compare the clinical effectiveness and outcomes of different blood pressure medications.

RECOVERY Trial (2020)

A rapid-deployment, randomized clinical platform trial established in 2020 to identify effective treatments for patients hospitalized with COVID-19.

RAND Health Insurance Experiment (1974–1982)

A large-scale randomized social experiment examining how different levels of patient cost-sharing affect healthcare utilization and overall health outcomes.